Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.47 SEK | -4.08% | -7.66% | -10.13% |
Apr. 16 | Mendus AB Announces Board Changes | CI |
Mar. 27 | Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML | CI |
Sales 2024 * | - | Sales 2025 * | 264M 24.27M | Capitalization | 473M 43.52M |
---|---|---|---|---|---|
Net income 2024 * | -130M -11.95M | Net income 2025 * | 132M 12.13M | EV / Sales 2024 * | - |
Net cash position 2024 * | 59.34M 5.45M | Net cash position 2025 * | 192M 17.63M | EV / Sales 2025 * | 1.07 x |
P/E ratio 2024 * |
-3.92
x | P/E ratio 2025 * |
3.76
x | Employees | 30 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.12% |
Latest transcript on Mendus AB
1 day | -4.08% | ||
1 week | -7.66% | ||
Current month | +4.44% | ||
1 month | +1.73% | ||
3 months | -1.05% | ||
6 months | +25.84% | ||
Current year | -10.13% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 74 | 01-12-31 | |
Erik Manting
CEO | Chief Executive Officer | 53 | - |
Lotta Ferm
DFI | Director of Finance/CFO | 58 | 21-02-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 12-12-31 | |
Helén Tuvesson
BRD | Director/Board Member | 62 | 19-12-31 |
Hans Preusting
BRD | Director/Board Member | 62 | 20-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.47 | -4.08% | 1,613,893 |
24-04-24 | 0.49 | -1.31% | 908,965 |
24-04-23 | 0.4965 | +1.33% | 607,145 |
24-04-22 | 0.49 | -2.00% | 1,110,513 |
24-04-19 | 0.5 | -1.77% | 1,209,764 |
Delayed Quote Nasdaq Stockholm, April 25, 2024 at 11:29 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.13% | 45.32M | |
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |
- Stock Market
- Equities
- IMMU Stock